Literature DB >> 10534125

MIP-3alpha induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/p44 MAPK).

S K Sullivan1, D A McGrath, F Liao, S A Boehme, J M Farber, K B Bacon.   

Abstract

The CC chemokine macrophage inflammatory protein-3alpha (MIP-3alpha) is the product of recent electronic cloning efforts, however, little characterization of its spectrum of biological effects has been undertaken. Human eosinophils exhibited pertussis-toxin-sensitive migration in response to human recombinant (hr)MIP-3alpha. Messenger RNA for the MIP-3alpha receptor, CCR-6, and low levels of surface expression were demonstrated by reverse transcriptase-polymerase chain reaction and FACS analysis. Analyses of cell signaling revealed dose-dependent increases in intracellular calcium mobilization, calcium transients that were, however, greatly reduced when compared with MCP-3-induced responses. Further investigations of MIP-3alpha-induced signal transduction revealed time- and dose-dependent, partially pertussis toxin-dependent, increases in phosphorylation of the p42/p44 mitogen-activated protein kinases (MAPK) that occurred at 10- to 100-fold lower concentrations, and that were linked to a phosphoinositide 3-kinase pathway. These results suggest that MIP-3alpha can regulate multiple, parallel signal transduction pathways in eosinophils, and suggest that MAPK activation by MIP-3alpha in eosinophils is a significant signaling pathway for migration induction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534125     DOI: 10.1002/jlb.66.4.674

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

Review 1.  Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.

Authors:  Adam P Curnock; Marisa K Logan; Stephen G Ward
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 2.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

Review 3.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

4.  Ectopic expression of CCL19 impairs alloimmune response in mice.

Authors:  Stefan Krautwald; Ekkehard Ziegler; Reinhold Förster; Lars Ohl; Kerstin Amann; Ulrich Kunzendorf
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

5.  Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa.

Authors:  Tong-Jun Lin; Lauren H Maher; Kaede Gomi; Jeffrey D McCurdy; Rafael Garduno; Jean S Marshall
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 6.  The Eosinophil in Health and Disease: from Bench to Bedside and Back.

Authors:  Wei Liao; Hai Long; Christopher Chia-Chi Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 7.  Chemokines, innate and adaptive immunity, and respiratory disease.

Authors:  I Sabroe; C M Lloyd; M K B Whyte; S K Dower; T J Williams; J E Pease
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

8.  Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation.

Authors:  N W Lukacs; D M Prosser; M Wiekowski; S A Lira; D N Cook
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

9.  The Phosphorylation of CCR6 on Distinct Ser/Thr Residues in the Carboxyl Terminus Differentially Regulates Biological Function.

Authors:  Mei-Yi Lu; Syuan-Shao Lu; Shiann-Luen Chang; Fang Liao
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.